Central Pharmaceutical JSC No2 (HSTC:DP2) EBIT per Share: ₫ (TTM As of . 20)


HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,500.00
View Full Analysis

What is Central Pharmaceutical JSC No2 EBIT per Share?

Central Pharmaceutical JSC No2 HSTC:DP2 23 EBIT per Share is ₫ as of . 20. GuruFocus rates HSTC:DP2 with a GF Score™ of 23/100.

Central Pharmaceutical JSC No2's EBIT per Share for the six months ended in . 20 was ₫0.00. Central Pharmaceutical JSC No2 does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Central Pharmaceutical JSC No2's EBIT per Share or its related term are showing as below:

HSTC:DP2's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.85
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Central Pharmaceutical JSC No2's EBIT for the six months ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2  (HSTC:DP2) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Central Pharmaceutical JSC No2 EBIT per Share Related Terms

Central Pharmaceutical JSC No2 EBIT per Share Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 EBIT per Share Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
EBIT per Share

Central Pharmaceutical JSC No2 Semi-Annual Data
EBIT per Share
HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Central Pharmaceutical JSC No2's EBIT per Share for the fiscal year that ended in . 20 is calculated as

EBIT per Share(A: . 20 )
=EBIT/Shares Outstanding (Diluted Average)
=/0
=N/A

Central Pharmaceutical JSC No2's EBIT per Share for the quarter that ended in . 20 is calculated as

EBIT per Share(Q: . 20 )
=EBIT/Shares Outstanding (Diluted Average)
=/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of ₫ mean?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a EBIT per Share of ₫ as of . 20. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Central Pharmaceutical JSC No2 and its competitors.
Is Central Pharmaceutical JSC No2's EBIT per Share too high?
Central Pharmaceutical JSC No2's current EBIT per Share is ₫. Overall, Central Pharmaceutical JSC No2 has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceutical JSC No2's EBIT per Share compare to ?
Central Pharmaceutical JSC No2's EBIT per Share of ₫ can be compared against companies in the Healthcare Providers & Services industry. The industry median EBIT per Share is 11.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.85, based on 530 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Central Pharmaceutical JSC No2 and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Central Pharmaceutical JSC No2's current EBIT per Share is ₫. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceutical JSC No2 stock overvalued right now?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a current EBIT per Share of ₫. The current EBIT per Share is ₫. Central Pharmaceutical JSC No2's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Central Pharmaceutical JSC No2 (HSTC:DP2), the current EBIT per Share is ₫ as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,500.00
Price